TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR

被引:158
|
作者
CHINI, B
MOUILLAC, B
ALA, Y
BALESTRE, MN
TRUMPPKALLMEYER, S
HOFLACK, J
ELANDS, J
HIBERT, M
MANNING, M
JARD, S
BARBERIS, C
机构
[1] INSERM,U401,F-34094 MONTPELLIER 05,FRANCE
[2] MARION MERRELL DOW RES INST,F-67080 STRASBOURG 05,FRANCE
[3] MED COLL OHIO,DEPT BIOCHEM,TOLEDO,OH 43699
来源
EMBO JOURNAL | 1995年 / 14卷 / 10期
关键词
AGONIST SELECTIVITY; DDAVP; MOLECULAR MODELING; RECEPTOR MUTAGENESIS; VASOPRESSIN RECEPTOR;
D O I
10.1002/j.1460-2075.1995.tb07211.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using a three-dimensional model of G protein-coupled receptors (GPCR), we have previously succeeded in docking the neurohypophysial hormone arginine-vasopressin (AVP) into the V1a receptor, According to this model, the hormone is completely embedded in the transmembrane part of the receptor. Only the side chain of the Arg residue at position 8 projects outside the transmembrane core of the receptor and possibly interacts with a Tyr residue located in the first extracellular loop at position 115. Residue 8 varies in the two natural neurohypophysial hormones, AVP and oxytocin (OT); similarly, different residues are present at position 115 in the different members of the AVP/OT receptor family. Here we show that Arg8 is crucial for high affinity binding of AVP to the rat V1a receptor. Moreover, when Tyr115 is replaced by an Asp and a Phe, the amino acids naturally occurring in the V2 and in the OT receptor subtypes, the agonist selectivity of the V1a receptor switches accordingly, Our results indicate that the interaction between peptide residue 8 and the receptor residue at position 115 is not only crucial for agonist high affinity binding but also for receptor selectivity.
引用
收藏
页码:2176 / 2182
页数:7
相关论文
共 50 条
  • [1] The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock
    Saad, Antonio F.
    Maybauer, Marc O.
    JOURNAL OF CRITICAL CARE, 2017, 40 : 41 - 45
  • [2] SELEPRESSIN, A NEW V1A RECEPTOR AGONIST: HEMODYNAMIC COMPARISON TO VASOPRESSIN IN DOGS
    Boucheix, Olivier B.
    Milano, Stephane P.
    Henriksson, Marie
    Reinheimer, Torsten M.
    SHOCK, 2013, 39 (06): : 533 - 538
  • [3] Transient phosphorylation of the V1a vasopressin receptor
    Innamorati, G
    Sadeghi, H
    Birnbaumer, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) : 7155 - 7161
  • [4] V1a Vasopressin Receptor and Mouse Reproductive Function
    Tsuchiya, Hiroyoshi
    Fujimura, Shyota
    Fujimura, Akio
    Fujiwara, Yoko
    Koshimizu, Taka-aki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (03) : S244 - S244
  • [5] Homologous and heterologous phosphorylation of the vasopressin V1a receptor
    Ancellin, N
    Preisser, L
    Le Maout, S
    Barbado, M
    Creminon, C
    Corman, B
    Morel, A
    CELLULAR SIGNALLING, 1999, 11 (10) : 743 - 751
  • [6] Involvement of vasopressin V1a receptor in the barorellex arc
    Oikawa, Ryo
    Nasa, Yoshihisa
    Ishii, Rie
    Kuwaki, Tomoyuki
    Tanoue, Akito
    Tsujimoto, Gozoh
    Takeo, Satoshi
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (06) : 1071 - 1072
  • [7] Structural determinants in V1a vasopressin receptor function
    Hawtin, SR
    Wheatley, M
    PEPTIDERGIC G PROTEIN-COUPLED RECEPTORS: FROM BASIC RESEARCH TO CLINICAL APPLICATIONS, 1999, 307 : 137 - 143
  • [8] A Selective V1A Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock
    He, Xinrong
    Su, Fuhong
    Taccone, Fabio Silvio
    Laporte, Regent
    Kjolbye, Anne Louise
    Zhang, Jing
    Xie, Keliang
    Moussa, Mouhamed Djahoum
    Reinheimer, Torsten Michael
    Vincent, Jean-Louis
    CRITICAL CARE MEDICINE, 2016, 44 (01) : 23 - 31
  • [9] Protective Mechanism of the Selective Vasopressin V1A Receptor Agonist Selepressin against Endothelial Barrier Dysfunction
    Barabutis, Nektarios
    Marinova, Margarita
    Solopov, Pavel
    Uddin, Mohammad A.
    Croston, Glenn E.
    Reinheimer, Torsten M.
    Catravas, John D.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2020, 375 (02): : 286 - 295
  • [10] Vasopressin V1a receptor is required for nucleocytoplasmic transport of mineralocorticoid receptor
    Hori, Kahori
    Nagai, Takanori
    Izumi, Yuichiro
    Kimura, Miho
    Hasuike, Yukiko
    Nakayama, Yushi
    Nanami, Masayoshi
    Tokuyama, Masanori
    Otaki, Yoshinaga
    Kuragano, Takahiro
    Kohda, Yukimasa
    Obinata, Masuo
    Kawahara, Katsumasa
    Tanoue, Akito
    Tomita, Kimio
    Nakanishi, Takeshi
    Nonoguchi, Hiroshi
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2012, 303 (07) : F1080 - F1088